Histologic Subtype Informs Real-World Immune Checkpoint Inhibitor Uptake in Patients with Malignant Pleural Mesothelioma

被引：0
|
作者：
Kim, R. [1 ]
Mitra, N. [2 ]
Bagley, S. J. [3 ]
Marmarelis, M. E. [3 ]
Haas, A. R. [1 ]
Rendle, K. A. [4 ]
Vachani, A. [1 ]
机构：
[1] Univ Penn, Div Pulm Allergy & Crit Care, Philadelphia, PA 19104 USA
[2] Univ Penn, Dept Biostat Epidemiol & Informat, Philadelphia, PA 19104 USA
[3] Univ Penn, Div Hematol & Oncol, Philadelphia, PA 19104 USA
[4] Univ Penn, Dept Family Med & Community Hlth, Philadelphia, PA 19104 USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2021年 / 203卷 / 09期
基金：
美国国家卫生研究院;
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A4760
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Immune Checkpoint Inhibitor Uptake in Real-World Patients With Malignant Pleural Mesothelioma
    Kim, Roger Y.
    Mitra, Nandita
    Bagley, Stephen J.
    Marmarelis, Melina E.
    Haas, Andrew R.
    Rendle, Katharine A.
    Vachani, Anil
    [J]. JTO CLINICAL AND RESEARCH REPORTS, 2021, 2 (06):
  • [2] Immune checkpoint inhibitor therapy for malignant pleural mesothelioma
    Nowak, Anna K.
    Chin, Wee Loong
    Keam, Synat
    Cook, Alistair
    [J]. LUNG CANCER, 2021, 162 : 162 - 168
  • [3] Immune-Checkpoint Inhibitors for Malignant Pleural Mesothelioma: A French, Multicenter, Retrospective Real-World Study
    Assie, Jean-Baptiste
    Crepin, Florian
    Grolleau, Emmanuel
    Canellas, Anthony
    Geier, Margaux
    Grebert-Manuardi, Aude
    Akkache, Nabila
    Renault, Aldo
    Hauss, Pierre-Alexandre
    Sabatini, Marielle
    Bonnefoy, Valentine
    Cortot, Alexis
    Wislez, Marie
    Gauvain, Clement
    Chouaid, Christos
    Scherpereel, Arnaud
    Monnet, Isabelle
    [J]. CANCERS, 2022, 14 (06)
  • [4] Multimodal Treatment of Malignant Pleural Mesothelioma: Real-World Experience with 112 Patients
    Holzknecht, Arnulf
    Illini, Oliver
    Hochmair, Maximilian J.
    Krenbek, Dagmar
    Setinek, Ulrike
    Huemer, Florian
    Bitterlich, Erwin
    Kaindl, Christoph
    Getman, Vladyslav
    Akan, Ahmet
    Weber, Michael
    Leobacher, Gunther
    Valipour, Arschang
    Mueller, Michael R.
    Watzka, Stefan B.
    [J]. CANCERS, 2022, 14 (09)
  • [5] Immune checkpoint inhibitors in malignant pleural mesothelioma
    Ceresoli, Giovanni Luca
    Mantovani, Alberto
    [J]. LANCET ONCOLOGY, 2017, 18 (05): : 559 - 561
  • [6] Real-world prognostic model for malignant pleural mesothelioma.
    Nasser, Abdullah
    Baird, Andrew
    Saint-Pierre, Mathieu D.
    Laurie, Scott A.
    Wheatley-Price, Paul
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [7] Real-world treatment for malignant pleural mesothelioma: the Belgian experience
    Rosskamp, M.
    Van Damme, N.
    De Schutter, H.
    Slabbaert, M.
    Henau, K.
    Praet, M.
    Nackaerts, K.
    Van Meerbeeck, J. P.
    [J]. EUROPEAN JOURNAL OF CANCER, 2017, 72 : S177 - S178
  • [8] Therapeutic outcome according to histologic subtype in 121 patients with malignant pleural mesothelioma
    Ceresoli, GL
    Locati, LD
    Ferreri, AJM
    Cozzarini, C
    Passoni, P
    Melloni, G
    Zannini, P
    Bolognesi, A
    Villa, E
    [J]. LUNG CANCER, 2001, 34 (02) : 279 - 287
  • [9] Accuracy of pleural biopsy using thoracoscopy for the diagnosis of histologic subtype in patients with malignant pleural mesothelioma
    Greillier, Laurent
    Cavailles, Arnaud
    Fraticelli, Anne
    Scherpereel, Arnaud
    Barlesi, Fabrice
    Tassi, Gianfranco
    Thomas, Pascal
    Astoul, Philippe
    [J]. CANCER, 2007, 110 (10) : 2248 - 2252
  • [10] Real-world use of systemic therapy in elderly patients with malignant pleural mesothelioma (MPM)
    Cedres, S.
    Assaf, J. D.
    Iranzo, P.
    Callejo, A.
    Pardo, N.
    Navarro, A.
    Martinez-Marti, A.
    Rodriguez, G.
    Monton, V.
    Gonzalo, J.
    Miquel, J. M.
    Pedrola, A.
    Dienstmann, R.
    Felip, E.
    [J]. ANNALS OF ONCOLOGY, 2019, 30
12345